GSK’s vaccine patent deals sharpen Europe’s RNA delivery battleground
GSK has settled its COVID-19 vaccine patent dispute with Moderna and secured an injunction against Pfizer-BioNTech over liposome delivery technology. The outcomes put intellectual property and the…
Intellisphere Research Desk ·